Testing effectiveness (Phase 2)Study completedNCT03571620
What this trial is testing
Safety and Efficacy Study of Q301 in Mild to Moderate Adolescents and Adults Atopic Dermatitis Patients
Who this might be right for
Atopic Dermatitis
Qurient Co., Ltd. 258